新华医疗(600587.SH)：华佗国际拟出售华检医疗不超过5%的股份

Core Viewpoint - Xinhua Medical (600587.SH) announced a plan to divest up to 5% of its subsidiary Huajian Medical's shares to focus on core business development and improve asset operation efficiency [1] Group 1 - The divestment will be executed through public market transactions, which may include continuous bidding, collective bidding, and block trading [1] - Huajian International will implement the reduction plan gradually based on a reasonable assessment of Huajian Medical's stock price and market trends [1] - The transaction price for the shares to be sold is currently undetermined [1]